| Analysis | Metabolite Name | Measured Value | Units | Strain | Treatment |
|---|---|---|---|---|---|
| NEGATIVE ION MODE | L-PHENYLALANINE | 84300 | Peak area | CRBN +/+ | anti-CD3 stimulation |
| NEGATIVE ION MODE | L-PHENYLALANINE | 87800 | Peak area | CRBN +/+ | anti-CD3 & anti-CD28 stimulation |
| NEGATIVE ION MODE | L-PHENYLALANINE | 109000 | Peak area | CRBN -/- | anti-CD3 & anti-CD28 stimulation |
| NEGATIVE ION MODE | L-PHENYLALANINE | 113000 | Peak area | CRBN -/- | anti-CD3 & anti-CD28 stimulation |
| NEGATIVE ION MODE | L-PHENYLALANINE | 127000 | Peak area | CRBN +/+ | anti-CD3 stimulation |
| NEGATIVE ION MODE | L-PHENYLALANINE | 129000 | Peak area | CRBN -/- | anti-CD3 & anti-CD28 stimulation |
| NEGATIVE ION MODE | L-PHENYLALANINE | 146000 | Peak area | CRBN -/- | anti-CD3 & anti-CD28 stimulation |
| NEGATIVE ION MODE | L-PHENYLALANINE | 156000 | Peak area | CRBN -/- | anti-CD3 stimulation |
| NEGATIVE ION MODE | L-PHENYLALANINE | 185000 | Peak area | CRBN +/+ | anti-CD3 stimulation |
| NEGATIVE ION MODE | L-PHENYLALANINE | 188000 | Peak area | CRBN -/- | anti-CD3 & anti-CD28 stimulation |
| NEGATIVE ION MODE | L-PHENYLALANINE | 196000 | Peak area | CRBN +/+ | anti-CD3 & anti-CD28 stimulation |
| NEGATIVE ION MODE | L-PHENYLALANINE | 200000 | Peak area | CRBN -/- | anti-CD3 stimulation |
| NEGATIVE ION MODE | L-PHENYLALANINE | 235000 | Peak area | CRBN +/+ | anti-CD3 stimulation |
| NEGATIVE ION MODE | L-PHENYLALANINE | 240000 | Peak area | CRBN -/- | anti-CD3 & anti-CD28 stimulation |
| NEGATIVE ION MODE | L-PHENYLALANINE | 244000 | Peak area | CRBN -/- | unstimulated |
| NEGATIVE ION MODE | L-PHENYLALANINE | 245000 | Peak area | CRBN +/+ | anti-CD3 stimulation |
| NEGATIVE ION MODE | L-PHENYLALANINE | 246000 | Peak area | CRBN -/- | anti-CD3 stimulation |
| NEGATIVE ION MODE | L-PHENYLALANINE | 249000 | Peak area | CRBN -/- | unstimulated |
| NEGATIVE ION MODE | L-PHENYLALANINE | 251000 | Peak area | CRBN -/- | unstimulated |
| NEGATIVE ION MODE | L-PHENYLALANINE | 257000 | Peak area | CRBN +/+ | anti-CD3 & anti-CD28 stimulation |
| NEGATIVE ION MODE | L-PHENYLALANINE | 262000 | Peak area | CRBN -/- | anti-CD3 stimulation |
| NEGATIVE ION MODE | L-PHENYLALANINE | 272000 | Peak area | CRBN +/+ | anti-CD3 & anti-CD28 stimulation |
| NEGATIVE ION MODE | L-PHENYLALANINE | 283000 | Peak area | CRBN +/+ | unstimulated |
| NEGATIVE ION MODE | L-PHENYLALANINE | 284000 | Peak area | CRBN -/- | unstimulated |
| NEGATIVE ION MODE | L-PHENYLALANINE | 289000 | Peak area | CRBN +/+ | anti-CD3 & anti-CD28 stimulation |
| NEGATIVE ION MODE | L-PHENYLALANINE | 305000 | Peak area | CRBN -/- | unstimulated |
| NEGATIVE ION MODE | L-PHENYLALANINE | 316000 | Peak area | CRBN +/+ | unstimulated |
| NEGATIVE ION MODE | L-PHENYLALANINE | 350000 | Peak area | CRBN +/+ | anti-CD3 stimulation |
| NEGATIVE ION MODE | L-PHENYLALANINE | 363000 | Peak area | CRBN +/+ | unstimulated |
| NEGATIVE ION MODE | L-PHENYLALANINE | 366000 | Peak area | CRBN -/- | anti-CD3 stimulation |
| NEGATIVE ION MODE | L-PHENYLALANINE | 368000 | Peak area | CRBN -/- | anti-CD3 stimulation |
| NEGATIVE ION MODE | L-PHENYLALANINE | 379000 | Peak area | CRBN +/+ | anti-CD3 stimulation |
| NEGATIVE ION MODE | L-PHENYLALANINE | 398000 | Peak area | CRBN +/+ | anti-CD3 & anti-CD28 stimulation |
| NEGATIVE ION MODE | L-PHENYLALANINE | 418000 | Peak area | CRBN -/- | unstimulated |
| NEGATIVE ION MODE | L-PHENYLALANINE | 421000 | Peak area | CRBN -/- | anti-CD3 stimulation |
| NEGATIVE ION MODE | L-PHENYLALANINE | 440000 | Peak area | CRBN -/- | unstimulated |
| NEGATIVE ION MODE | L-PHENYLALANINE | 486000 | Peak area | CRBN +/+ | anti-CD3 stimulation |
| NEGATIVE ION MODE | L-PHENYLALANINE | 543000 | Peak area | CRBN -/- | anti-CD3 stimulation |
| NEGATIVE ION MODE | L-PHENYLALANINE | 581000 | Peak area | CRBN -/- | unstimulated |
| NEGATIVE ION MODE | L-PHENYLALANINE | 586000 | Peak area | CRBN +/+ | unstimulated |
| NEGATIVE ION MODE | L-PHENYLALANINE | 702000 | Peak area | CRBN +/+ | unstimulated |
| NEGATIVE ION MODE | L-PHENYLALANINE | 769000 | Peak area | CRBN -/- | anti-CD3 stimulation |
| NEGATIVE ION MODE | L-PHENYLALANINE | 815000 | Peak area | CRBN -/- | unstimulated |
| NEGATIVE ION MODE | L-PHENYLALANINE | 834000 | Peak area | CRBN +/+ | unstimulated |
| NEGATIVE ION MODE | L-PHENYLALANINE | 836000 | Peak area | CRBN +/+ | unstimulated |
| NEGATIVE ION MODE | L-PHENYLALANINE | 840000 | Peak area | CRBN -/- | unstimulated |
| NEGATIVE ION MODE | L-PHENYLALANINE | 976000 | Peak area | CRBN +/+ | anti-CD3 & anti-CD28 stimulation |
| NEGATIVE ION MODE | L-PHENYLALANINE | 1060000 | Peak area | CRBN +/+ | anti-CD3 & anti-CD28 stimulation |
| NEGATIVE ION MODE | L-PHENYLALANINE | 1300000 | Peak area | CRBN +/+ | unstimulated |
| NEGATIVE ION MODE | L-PHENYLALANINE | 1360000 | Peak area | CRBN -/- | anti-CD3 & anti-CD28 stimulation |
| NEGATIVE ION MODE | L-PHENYLALANINE | 1430000 | Peak area | CRBN -/- | anti-CD3 & anti-CD28 stimulation |
| NEGATIVE ION MODE | L-PHENYLALANINE | 1680000 | Peak area | CRBN +/+ | anti-CD3 stimulation |
| NEGATIVE ION MODE | L-PHENYLALANINE | 1740000 | Peak area | CRBN -/- | anti-CD3 stimulation |
| NEGATIVE ION MODE | L-PHENYLALANINE | 2050000 | Peak area | CRBN +/+ | anti-CD3 stimulation |
| NEGATIVE ION MODE | L-PHENYLALANINE | 3290000 | Peak area | CRBN +/+ | unstimulated |
| NEGATIVE ION MODE | L-PHENYLALANINE | 3350000 | Peak area | CRBN -/- | anti-CD3 & anti-CD28 stimulation |
| NEGATIVE ION MODE | L-PHENYLALANINE | 4900000 | Peak area | CRBN +/+ | anti-CD3 & anti-CD28 stimulation |
| NEGATIVE ION MODE | L-PHENYLALANINE | 6740000 | Peak area | CRBN -/- | anti-CD3 & anti-CD28 stimulation |
| NEGATIVE ION MODE | L-PHENYLALANINE | 10600000 | Peak area | CRBN +/+ | anti-CD3 & anti-CD28 stimulation |
| NEGATIVE ION MODE | L-PHENYLALANINE | 50300000 | Peak area | CRBN +/+ | unstimulated |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|